Active	Status	Sponsor type	Region	Phase	Filter
5 Active 2 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vries, E GE de
NCT02478099 / 2015-000907-19: MPDL3280A-treatment-IST-UMCG	Active, not recruiting	2	81	Europe	MPDL3280A	University Medical Center Groningen	Locally Advanced or Metastatic Solid Tumors	09/23	07/24
NCT04029181: ImmunoPET With an Anti-CD8 Imaging Agent	Active, not recruiting	1/2	47	Europe	Anti-CD8 PET imaging agent	University Medical Center Groningen	Metastatic Cancer, Unresectable Malignant Neoplasm	12/22	12/24
NCT04706715 / 2020-004052-15: LAG3 PET Imaging in Advanced Solid Tumors	Active, not recruiting	1/2	41	Europe	89Zr-DFO-REGN3767, Cemiplimab	University Medical Center Groningen, Regeneron Pharmaceuticals	Metastatic Solid Tumor	09/24	09/24
VOICE, NCT04715438 / 2021-000872-13: Vaccination Against COVID-19 in Cancer	Active, not recruiting	N/A	791	Europe	mRNA-1273 SARS-CoV-2 vaccine from Moderna	University Medical Center Groningen	Cancer	06/21	04/25
POINTING, NCT04193956: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors	Recruiting	N/A	3500	Europe	Standard-of-care procedures, Study procedures	University Medical Center Groningen	Melanoma, Non-Small Cell Lung Cancer	09/24	09/24